Description: Rabbit polyclonal antibody to CD184 (Phospho-S339) Immunogen: KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding S339 of human CD184 protein. The exact sequence is proprietary. Purification: The antibody was purified by immunogen affinity chromatography. Clonality: Polyclonal Form: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. Dilution: WB (1/500 - 1/1000), IH (1/50 - 1/100), IF/IC (1/50 - 1/200) Gene Symbol: CXCR4 Alternative Names: C-X-C chemokine receptor type 4; CXC-R4; CXCR-4; FB22; Fusin; HM89; LCR1; Leukocyte-derived seven transmembrane domain receptor; LESTR; Lipopolysaccharide-associated protein 3; LAP-3; LPS-associated protein 3; NPYRL; Stromal cell-derived factor 1 receptor; SDF-1 receptor; CD184Entrez Gene (Human): 7852Entrez Gene (Mouse) : 12767SwissProt (Human): P61073SwissProt (Mouse) : P70658SwissProt (Rat) : O08565Storage/Stability : Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of CD184 (Phospho-S339) expression in Myla2059 (A), K562 (B), Jurkat (C) whole cell lysates.
-
Immunohistochemical analysis of CD184 (Phospho-S339) staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
-
Immunofluorescent analysis of CD184 (Phospho-S339) staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a hidified chamber. Cells were washed with PBST and incubated with a AF594-conjugated secondary antibody (red) in PBS at room temperature in the dark.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system
PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1)
The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants
Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction
Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10 dopaminergic neurons
CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia
HGF-induced PKC activation increases functional CXCR4 expression in human breast cancer cells
Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB(2) in Modulating Breast Cancer Growth and Invasion